Vimarsana
Biggest News Aggregation in the World

Page 2 - Akouos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akouos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akouos Today - Breaking & Trending Today

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research - Vimarsana News

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes AK-OTOF, […]

Akouos (NASDAQ:AKUS) Upgraded to "Hold" by Zacks Investment Research - Vimarsana News

Akouos (NASDAQ:AKUS) Upgraded to "Hold" by Zacks Investment Research

Zacks Investment Research upgraded shares of Akouos (NASDAQ:AKUS – Get Rating) from a sell rating to a hold rating in a research note published on Wednesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes […]

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research - Vimarsana News

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes AK-OTOF, […]

Zacks Investment Research Upgrades Akouos (NASDAQ:AKUS) to "Hold" - Vimarsana News

Zacks Investment Research Upgrades Akouos (NASDAQ:AKUS) to "Hold"

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes […]

Akouos (NASDAQ:AKUS) Downgraded by Zacks Investment Research to Sell - Vimarsana News

Akouos (NASDAQ:AKUS) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of Akouos (NASDAQ:AKUS – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product […]